| Financial Year |
March 31 2023 |
| Monetary Funds |
616,254,831.46 |
| Held-for-trading Financial Assets |
661,027,313.55 |
| Notes Receivable |
701,408,581.07 |
| Accounts Receivable |
1,525,353,322.25 |
| Advances to Suppliers |
41,037,736.97 |
| Other Receivables |
16,377,060.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
561,543,733.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,792,178.22 |
| Total Current Assets |
4,231,834,867.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,407,238.98 |
| Investment Properties |
-- |
| Fixed Assetes |
451,915,236.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,917,937.66 |
| R&D expenses |
-- |
| Goodwill |
440,494,712.76 |
| Long-Term Deferred and Prepaid Expenses |
2,688,975.59 |
| Deferred Income Tax Assets |
109,166,315.26 |
| Other Non-Current Assets |
1,466,690.66 |
| Sub-Total of Non-Current Assets |
1,342,124,605.29 |
| Total Assets |
5,573,959,472.66 |
| Short-Term Loans |
608,533,861.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
513,314,131.01 |
| Accounts Payable |
930,821,288.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,852,252.83 |
| Taxes Payable |
88,478,573.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,532,653.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,587,950.09 |
| Other Current Liabilities |
17,121,900.47 |
| Sub-Total of Current Liabilities |
2,317,331,851.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,706,000.00 |
| Deferred Income Tax Liabilities |
3,392.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,989,932.60 |
| Total Liabilities |
2,330,321,784.25 |
| Paid-In Capital(Or Share Stock) |
497,511,290.00 |
| Capital Surplus |
1,823,633,378.56 |
| Surplus Reserve |
118,905,846.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
812,187,397.53 |
| Minority Stockholder's Interest |
1,267,375.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,242,370,313.11 |
| Owner's Equity（Stockholder's Equity） |
3,243,637,688.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,573,959,472.66 |
